A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).
Keros Therapeutics, Inc.
Keros Therapeutics, Inc.
University of Nebraska
Rutgers, The State University of New Jersey
Northwestern University
University of California, San Francisco